The Rebuild Neuropathy Protocol™: 6 Treatment Modalities, 1 Root Cause Diagnosis First

Neuropathy treatment at Rebuild Regen Medical Clinic is a multi-modal diagnostic protocol that identifies the root cause of nerve damage first — diabetic, peripheral, compressive, or metabolic — before building a custom treatment plan around it.

This distinction is not marketing language. It reflects a fundamental difference in clinical philosophy that separates Rebuild Regen's approach from the neuropathy industry's standard model, where patients are enrolled in pre-packaged programs ranging from $10,000 to $20,000 regardless of their specific neuropathy type, severity, or root cause. At Rebuild Regen, the diagnosis drives the protocol. The treatment plan is built after Elizabeth Celestin, APRN, FNP-C, understands what is actually causing your nerve damage.

Most patients with neuropathy arrive at this clinic having been told that nerve damage is irreversible and that management of symptoms is the best they can hope for. That is sometimes true. It is not always true. The accuracy of that prognosis depends heavily on the type of neuropathy, the duration of nerve compression or damage, and whether the root cause has been adequately addressed. None of those questions are answered by a one-size-fits-all treatment enrollment.

What Neuropathy Treatment Is — Not a Program, a Diagnosis-First Protocol

Neuropathy is a category of conditions, not a single disease. The word describes damage to or dysfunction of the peripheral nervous system — the nerves outside the brain and spinal cord. That damage can originate from radically different causes and require radically different interventions.

Treating all neuropathy patients with the same protocol is like treating all knee pain patients with the same injection. A torn ligament, advanced arthritis, a meniscus condition, and IT band syndrome all produce knee pain. The right treatment for each is different. The same logic applies to neuropathy.

The Rebuild Neuropathy Protocol™ begins with an evaluation designed to identify the neuropathy type before any treatment is recommended:

What are the symptoms? Burning, numbness, tingling, sharp pain, weakness, balance problems? Location — feet and legs, hands, one side vs. both?
When did symptoms begin and what was happening in the patient's life at that time?
What is the patient's metabolic status? Diabetes, prediabetes, insulin resistance?
What medications is the patient taking? Chemotherapy, statins, antibiotics, and other drugs are known neuropathy triggers.
Is there a compressive element — lumbar disc herniation, stenosis, piriformis involvement?
What are the hormone levels? Thyroid, testosterone, estrogen — hormonal deficiency is a frequently missed neuropathy driver.
What is the nutritional picture? B12, folate, and alpha-lipoic acid deficiency patterns?

This intake process informs which of the six available modalities are included in the patient's specific protocol and in what sequence and intensity.

Root Cause Categories — Diabetic, Peripheral, Compressive, Metabolic, Chemo-Induced

Diabetic neuropathy: The most common form of peripheral neuropathy in the United States. Chronic hyperglycemia damages small blood vessels that supply peripheral nerves, causing progressive nerve degeneration. Diabetic neuropathy typically presents symmetrically in the feet and lower legs (stocking-glove pattern). It worsens with poor glycemic control. Treatment at Rebuild Regen addresses both local nerve support (laser, IV nutritional infusion) and metabolic optimization (if the patient's diabetes management can be supported through the peptide/hormonal protocols).

Peripheral neuropathy (idiopathic and non-diabetic): Nerve damage without an identifiable metabolic cause. Idiopathic peripheral neuropathy — no confirmed cause found — is a common diagnosis that often reflects an incomplete diagnostic workup. Elizabeth specifically investigates nutritional deficiencies, environmental toxin exposure, heavy metal accumulation, inflammatory conditions, and autoimmune patterns when patients arrive with this label.

Compressive neuropathy: Nerve damage resulting from mechanical compression — lumbar disc herniation producing sciatic nerve compression, spinal stenosis, piriformis syndrome, carpal tunnel, or tarsal tunnel syndrome. These have a mechanical component that may respond to decompression (Antalgic-Trac® spinal decompression or specific targeted interventions) in addition to regenerative and nutritional support.

Metabolic neuropathy: Thyroid disease, B12 deficiency, folate deficiency, and other metabolic conditions produce neuropathy. Hypothyroidism-related neuropathy is particularly under-recognized. These cases require addressing the metabolic root cause first; supportive neuropathy treatment accelerates the recovery once the primary driver is managed.

Chemotherapy-induced peripheral neuropathy (CIPN): Many chemotherapy agents produce peripheral neuropathy as a side effect. CIPN may be temporary or persistent after chemotherapy completion. It frequently involves both sensory and motor nerve dysfunction. Treatment focuses on nerve regeneration support through Class IV laser, IV nutritional infusion, and anti-inflammatory protocols appropriate to post-oncology patients.

The Rebuild Neuropathy Protocol™ Modalities

The protocol draws from six available treatment modalities, allocated based on root cause diagnosis:

1. LightForce® XLi Class IV Therapy Laser: High-powered photobiomodulation targeting the nerve tissue along the affected dermatome. The LightForce® XLi penetrates deeper than Class III devices, delivering energy directly to nerve fibers and supporting mitochondrial function in damaged nerve cells. Clinical studies have shown Class IV laser to promote nerve conduction velocity, reduce neuroinflammation, and support axonal regeneration. For most neuropathy patients, laser is a core modality in the protocol.

2. Chattanooga Intelect RPW 2 Shockwave Therapy: For neuropathy cases with significant microvascular compromise (common in diabetic neuropathy), shockwave therapy stimulates angiogenesis — the formation of new capillaries — increasing blood flow to oxygen-deprived nerve tissue. The Chattanooga Intelect RPW 2 delivers radial pressure waves to targeted tissue zones identified in the diagnostic evaluation.

3. IV Nutritional Infusions: Intravenous delivery of key nerve-support nutrients at therapeutic doses: B12 (methylcobalamin), alpha-lipoic acid (ALA), NAD+, and thiamine. Oral supplementation of these compounds has variable absorption. IV delivery bypasses GI absorption entirely and achieves tissue concentrations not achievable orally. B12 and ALA have the strongest evidence base for neuropathy support; NAD+ addresses mitochondrial function and cellular energy in damaged nerve tissue.

4. Hormonal Correction: For patients whose root cause evaluation reveals thyroid dysfunction, testosterone deficiency, or estrogen deficiency as a contributing factor, hormonal correction is a prerequisite — not an optional add-on. Treating neuropathy symptoms without correcting the hormonal environment that is driving nerve dysfunction produces limited results. Elizabeth coordinates the hormonal correction through the HRT or TRT protocol alongside neuropathy treatment.

5. Metabolic Optimization: For diabetic and prediabetic neuropathy, metabolic control is part of the treatment architecture. Peptide protocols including semaglutide or tirzepatide may be relevant for patients with significant insulin resistance or obesity-related metabolic dysfunction. Weight reduction and improved glycemic control directly slow the progression of diabetic neuropathy.

6. Mechanical Decompression: For compressive neuropathy involving spinal or joint mechanical components, the Antalgic-Trac® spinal decompression system is available to address disc-related nerve compression. Reducing the compressive load on the affected nerve is essential before regenerative or nutritional support can fully take hold.

The final protocol for each patient draws from these six modalities in the combination and intensity appropriate to their specific root cause. A patient with idiopathic peripheral neuropathy and B12 deficiency receives a different protocol than a patient with diabetic neuropathy and poor glycemic control. That specificity is the point.

Competitive De-Positioning — What Makes This Different

Most neuropathy clinics in South Florida operate on a program model: a fixed bundle of treatments — typically laser, electrical stimulation, and some dietary counseling — sold as a complete program for a set price between $10,000 and $20,000. The price is presented before diagnosis. The same program is sold to every neuropathy patient regardless of their type.

This model exists because it is profitable and requires minimal clinical infrastructure. It does not require a provider with a diagnostic background. It does not require individualized lab review. It does not require the clinical judgment to recognize that one patient needs metabolic optimization, another needs hormonal correction, and a third needs spinal decompression.

Elizabeth came from emergency medicine. She thinks diagnostically by training and temperament. She does not sell programs. She builds protocols. The Rebuild Neuropathy Protocol™ is named because it reflects a genuine methodology, not a marketing concept.

Patients who have been through $15,000 neuropathy programs without durable results are the most common referral source for new patients at this clinic. The conversation Elizabeth has with those patients begins with understanding what was actually tried and what the actual diagnosis underlying their neuropathy is.

Is the Rebuild Neuropathy Protocol™ Right for Your Type of Neuropathy?

The protocol is appropriate for patients with confirmed or suspected peripheral neuropathy — diabetic, idiopathic, metabolic, compressive, or chemotherapy-induced — who want a diagnosis-first evaluation and a custom treatment plan rather than a pre-packaged enrollment.

It is appropriate for patients who have had neuropathy treatment elsewhere with incomplete results and want to understand why.

It is appropriate for patients at early stages of neuropathy who want to arrest progression and support nerve regeneration before damage becomes more advanced.

It is less likely to produce significant results in patients with very long-standing, advanced neuropathy where nerve fiber loss has been substantial and the remaining nerve tissue is limited in its regenerative capacity. Elizabeth is direct about this during the intake evaluation.

Frequently Asked Questions

Is neuropathy reversible?

Nerve damage reversal depends on neuropathy type, duration, and severity. Early-stage neuropathy with an addressable root cause responds well to combined treatment approaches. Long-standing severe neuropathy with significant axonal loss has limited reversal capacity, though symptom management and progression arrest remain meaningful clinical goals. Elizabeth gives you a realistic prognosis during the initial evaluation based on your specific presentation.

How long does the protocol take?

The Rebuild Neuropathy Protocol™ is not a fixed-session count. The treatment frequency and duration are tailored to the patient. Most patients see an initial evaluation phase of 6 to 12 treatment sessions over 4 to 8 weeks, followed by a reassessment and protocol adjustment. Some patients continue with maintenance sessions after the initial phase; others reach a durable endpoint.

Is the laser treatment painful?

LightForce® XLi Class IV laser treatment is non-invasive and typically described as a warm sensation over the treatment area. Some patients with significant nerve sensitivity report mild transient discomfort during the first sessions. There is no broken skin, no needles, and no recovery time for laser sessions.

Do I need a referral?

No referral is required. Patients self-refer directly. If you have records from a neurologist, podiatrist, or other specialist who has evaluated your neuropathy, bring those to the first appointment — they help Elizabeth complete the diagnostic picture more efficiently.

Does insurance cover neuropathy treatment?

IV infusions, Class IV laser, and peptide protocols are generally not covered by insurance. Physical medicine components (shockwave, spinal decompression) may have partial coverage depending on your plan. The clinic provides documentation to support out-of-network reimbursement requests where applicable.

What is alpha-lipoic acid and why is it used for neuropathy?

Alpha-lipoic acid (ALA) is a mitochondrial antioxidant with both water and fat solubility — unusual properties that allow it to function in multiple cellular environments. ALA has been studied for diabetic neuropathy in particular, with European clinical trials supporting its use for sensory symptom reduction. IV delivery achieves plasma concentrations significantly higher than oral supplementation. At Rebuild Regen, IV ALA is a standard component of the nutritional infusion protocol for metabolic and diabetic neuropathy presentations.

When Neuropathy Has Progressed Beyond Conservative Intervention

Neuropathy that has progressed to severe axonal degeneration, complete loss of sensation in large tissue areas, significant motor weakness affecting gait and daily function, or autonomic neuropathy producing cardiovascular or gastrointestinal dysfunction represents a severity level that requires neurological specialist involvement alongside or instead of the Rebuild Neuropathy Protocol™. Elizabeth identifies these presentations at intake and coordinates referral when appropriate. The goal is always the most effective clinical path for the patient — not every neuropathy patient belongs in a regenerative medicine clinic.

Rebuild Regen Medical Clinic 3320 N Federal Hwy #101, Lighthouse Point, FL 33064 (954) 953-4208 | rebuildregenmedical.com

Schedule a Neuropathy Evaluation | Class IV Laser Therapy | Shockwave Therapy